Sarepta Therapeutics
SRPT
SRPT
407 hedge funds and large institutions have $11.9B invested in Sarepta Therapeutics in 2020 Q2 according to their latest regulatory filings, with 89 funds opening new positions, 128 increasing their positions, 130 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.03% more ownership
Funds ownership: 94.75% → 94.78% (+0.03%)
2% less repeat investments, than reductions
Existing positions increased: 128 | Existing positions reduced: 130
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Holders
407
Holding in Top 10
6
Calls
$311M
Puts
$245M
Top Buyers
| 1 | +$133M | |
| 2 | +$91.9M | |
| 3 | +$81M | |
| 4 |
BlackRock
New York
|
+$77.7M |
| 5 |
JP Morgan Chase
New York
|
+$69.5M |
Top Sellers
| 1 | -$148M | |
| 2 | -$63.7M | |
| 3 | -$61.5M | |
| 4 |
O
OrbiMed
New York
|
-$55M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$52.1M |